378 related articles for article (PubMed ID: 20439847)
1. Leptomeningeal metastases in the MRI era.
Clarke JL; Perez HR; Jacks LM; Panageas KS; Deangelis LM
Neurology; 2010 May; 74(18):1449-54. PubMed ID: 20439847
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal metastasis: Clinical experience of 519 cases.
Hyun JW; Jeong IH; Joung A; Cho HJ; Kim SH; Kim HJ
Eur J Cancer; 2016 Mar; 56():107-114. PubMed ID: 26841095
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge.
Passarin MG; Sava T; Furlanetto J; Molino A; Nortilli R; Musso AM; Zaninelli M; Franceschi T; Orrico D; Marangoni S; Dealis C; Graiff C; Filippo R; Grisanti S; Simoncini E; Vassalli L; Berruti A; Pedersini R
Neurol Sci; 2015 Jan; 36(1):117-23. PubMed ID: 25022241
[TBL] [Abstract][Full Text] [Related]
4. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.
Waki F; Ando M; Takashima A; Yonemori K; Nokihara H; Miyake M; Tateishi U; Tsuta K; Shimada Y; Fujiwara Y; Tamura T
J Neurooncol; 2009 Jun; 93(2):205-12. PubMed ID: 19043775
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers.
Nakagawa K; Takano K; Nishino K; Ohe S; Nakayama T; Arita H
J Neurooncol; 2024 May; 167(3):397-406. PubMed ID: 38430420
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis.
Straathof CS; de Bruin HG; Dippel DW; Vecht CJ
J Neurol; 1999 Sep; 246(9):810-4. PubMed ID: 10525979
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.
Oechsle K; Lange-Brock V; Kruell A; Bokemeyer C; de Wit M
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1729-35. PubMed ID: 20204406
[TBL] [Abstract][Full Text] [Related]
9. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
10. [Spinal metastases combined with leptomeningeal metastasis: A case report].
Ma LJ; Hu PP; Liu XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):563-566. PubMed ID: 37291936
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive neuraxis imaging in leptomeningeal metastasis: a retrospective case series.
Chamberlain MC
CNS Oncol; 2013 Mar; 2(2):121-8. PubMed ID: 25057975
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
14. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
[TBL] [Abstract][Full Text] [Related]
15. Management of leptomeningeal metastases: Prognostic factors and associated outcomes.
Brower JV; Saha S; Rosenberg SA; Hullett CR; Ian Robins H
J Clin Neurosci; 2016 May; 27():130-7. PubMed ID: 26778048
[TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal metastasis.
DeAngelis LM; Boutros D
Cancer Invest; 2005; 23(2):145-54. PubMed ID: 15813508
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients.
Du C; Hong R; Shi Y; Yu X; Wang J
J Neurooncol; 2013 Nov; 115(2):285-91. PubMed ID: 24000114
[TBL] [Abstract][Full Text] [Related]
18. A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.
Yin K; Li YS; Zheng MM; Jiang BY; Li WF; Yang JJ; Tu HY; Zhou Q; Zhong WZ; Yang XN; Chen HJ; Yan HH; Li LL; Wu YL; Zhang XC
Lung Cancer; 2019 May; 131():134-138. PubMed ID: 31027690
[TBL] [Abstract][Full Text] [Related]
19. Imaging features of leptomeningeal metastases.
Collie DA; Brush JP; Lammie GA; Grant R; Kunkler I; Leonard R; Gregor A; Sellar RJ
Clin Radiol; 1999 Nov; 54(11):765-71. PubMed ID: 10580769
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Analysis of the Clinical Outcomes of Leptomeningeal Metastasis in Patients with Solid Tumors.
Kim H; Lee EM
Brain Tumor Res Treat; 2018 Oct; 6(2):54-59. PubMed ID: 30381917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
